Brainstorm Cell Therapeutics Inc.

DB:GHD Stock Report

Market Cap: €9.4m

Brainstorm Cell Therapeutics Management

Management criteria checks 1/4

Brainstorm Cell Therapeutics' CEO is Chaim Lebovits, appointed in Jan 2023, has a tenure of 1.83 years. total yearly compensation is $1.13M, comprised of 39.1% salary and 60.9% bonuses, including company stock and options. directly owns 1.42% of the company’s shares, worth €133.33K. The average tenure of the management team and the board of directors is 1.8 years and 6.7 years respectively.

Key information

Chaim Lebovits

Chief executive officer

US$1.1m

Total compensation

CEO salary percentage39.1%
CEO tenure1.8yrs
CEO ownership1.4%
Management average tenure1.8yrs
Board average tenure6.7yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Chaim Lebovits's remuneration changed compared to Brainstorm Cell Therapeutics's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$14m

Jun 30 2024n/an/a

-US$13m

Mar 31 2024n/an/a

-US$16m

Dec 31 2023US$1mUS$442k

-US$17m

Sep 30 2023n/an/a

-US$17m

Jun 30 2023n/an/a

-US$22m

Mar 31 2023n/an/a

-US$24m

Dec 31 2022US$1mUS$500k

-US$24m

Sep 30 2022n/an/a

-US$25m

Jun 30 2022n/an/a

-US$24m

Mar 31 2022n/an/a

-US$23m

Dec 31 2021US$1mUS$500k

-US$24m

Sep 30 2021n/an/a

-US$30m

Jun 30 2021n/an/a

-US$29m

Mar 31 2021n/an/a

-US$30m

Dec 31 2020US$2mUS$500k

-US$32m

Sep 30 2020n/an/a

-US$28m

Jun 30 2020n/an/a

-US$29m

Mar 31 2020n/an/a

-US$26m

Dec 31 2019US$1mUS$500k

-US$23m

Sep 30 2019n/an/a

-US$21m

Jun 30 2019n/an/a

-US$18m

Mar 31 2019n/an/a

-US$17m

Dec 31 2018US$2mUS$500k

-US$14m

Sep 30 2018n/an/a

-US$8m

Jun 30 2018n/an/a

-US$8m

Mar 31 2018n/an/a

-US$5m

Dec 31 2017US$1mUS$391k

-US$5m

Compensation vs Market: Chaim's total compensation ($USD1.13M) is above average for companies of similar size in the German market ($USD476.59K).

Compensation vs Earnings: Chaim's compensation has increased whilst the company is unprofitable.

CEO

Chaim Lebovits (53 yo)

1.8yrs

Tenure

US$1,128,795

Compensation

Mr. Chaim Lebovits is President & Chief Executive Officer of Brainstorm Cell Therapeutics Inc. from January 2023. Mr. Lebovits was Chief Executive Officer of Brainstorm Cell Therapeutics Inc. from April 20...

Leadership Team

NamePositionTenureCompensationOwnership
Chaim Lebovits
President & CEO1.8yrsUS$1.13m1.42%
€ 133.3k
Irit Arbel
Co-Founder & Independent Vice Chair of the Board20.5yrsno data0.18%
€ 17.1k
Alla Patlis
Interim CFO & Controller11.9yrsUS$146.78k0.076%
€ 7.2k
Uri Yablonka
Executive VP7.7yrsUS$247.06k0.15%
€ 13.9k
Hartoun Hartounian
Executive VP & COOless than a yearno datano data
Daniel Offen
Chief Scientific Advisorno datano datano data
Mary Turner
Senior Vice President of Patient Advocacy & Government Affairs2.8yrsno datano data
Ibrahim Dagher
Executive VP & Chief Medical Officer1.3yrsno data0.22%
€ 20.9k
Netta Blondheim-Shraga
Senior Vice President of Research and Developmentless than a yearno datano data

1.8yrs

Average Tenure

54yo

Average Age

Experienced Management: GHD's management team is not considered experienced ( 1.8 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Irit Arbel
Co-Founder & Independent Vice Chair of the Board20.5yrsno data0.18%
€ 17.1k
Uri Yablonka
Executive VP10.4yrsUS$247.06k0.15%
€ 13.9k
Jacob Frenkel
Independent Chairman of the Board4.7yrsno data0.066%
€ 6.2k
Stanley Appel
Member of Scientific Advisory Boardno datano datano data
Andrew Card
Member of Business Advisory Board13.7yrsno datano data
Amit Bar-Or
Member of Scientific Advisory Boardno datano datano data
Rasheda Ali
Member of Business Advisory Board17.1yrsno datano data
Jerold Chun
Chairman of Scientific Advisory Board6.7yrsno datano data
Anthony Polverino
Independent Director6.8yrsUS$12.50k0.030%
€ 2.9k
Ralph Kern
Member of Scientific Advisory Board1.8yrsUS$4.46mno data
Stacy Lindborg
Directorless than a yearUS$1.01m0.42%
€ 39.8k
Nir Naor
Independent Director1.4yrsno datano data

6.7yrs

Average Tenure

64yo

Average Age

Experienced Board: GHD's board of directors are considered experienced (6.7 years average tenure).